Premium
REMARC STUDY: CORRELATION OF LYMPHOMA PD AND DEATH AND HEALTH‐RELATED QOL WITH MAINTENANCE LENALIDOMIDE VS PLACEBO IN ELDERLY DLBCL PATIENT RESPONDERS TO R‐CHOP
Author(s) -
Thieblemont C.,
Casasnovas R.,
Mounier N.,
Perrot A.,
Morschhauser F.,
Tilly H.,
Fruchart C.,
Corront B.,
Haouin C.,
Van Eygen K.,
Obéric L.,
Bouabdallah R.,
Sebban C.,
Bordessoule D.,
Fitoussi O.,
Van Hoof A.,
Eisenmann J.C.,
LionneHuyghe P.,
Deeren D.,
Gomes Da Silva M.,
Trotman J.,
Grosicki S.,
Greil R.,
Caballero D.,
Coiffier B.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2437_91
Subject(s) - medicine , lenalidomide , clinical endpoint , quality of life (healthcare) , placebo , randomization , population , relative risk , randomized controlled trial , surgery , confidence interval , multiple myeloma , alternative medicine , pathology , nursing , environmental health